Stocks News
-
BXSY: Monster Discount Continues to Grow (OTCMKTS:BXSY)
Incredi VFX Written by Nick Ackerman and co-produced by Stanford Chemist. Last time we covered Bexil Investment Trust (OTCPK:BXSY), the…
Read More » -
Walmart closes medical centers and telemedicine services
Walmart Inc. said Tuesday it is closing Walmart Health, which provides primary care, lab and other services, and Walmart Health…
Read More » -
Alphabet first in first quarter profits
There’s been a bit of a trend in Magnificent Seven stock this year. In February meta platform (NASDAQ:META) introduced quarterly…
Read More » -
3 Marijuana Stocks to Watch During Legalization Policy Shift
The legalization of marijuana has sparked considerable controversy in recent years. While some see this as a positive development due…
Read More » -
Bearish Stick Sandwich Pattern – Psychology and Trading Ideas
Bearish Stick Sandwich Pattern: Technical analysts rely heavily on charts and candlestick patterns to thoroughly analyze stock prices and accurately…
Read More » -
DP Trading Room: Magnificent 7’s Medium-Term View | decision point
Today, Carl focuses on the Magnificent 7 by looking at a mid-term review using not only daily charts but also…
Read More » -
Cryptocurrency Forecast Using Technical Indicators: April 30, 2024 – Analysis and Forecast – April 30, 2024
basic. 2: Every day. The daily chart is giant The divergence of the fast and slow moving averages prohibits further…
Read More » -
Stock Market: Stock Market Update: Most Active Stocks on the Market Currently by Trading Volume
New Delhi: Vodafone Idea (Shares traded: 95.49 billion), YES Bank (Shares traded: 269.8 billion), NHPC (Shares traded: 11.05 billion), PNB…
Read More » -
US stock futures fell ahead of the Federal Reserve meeting. Key Earnings Expected By Investing.com
Investing.com– U.S. stock index futures were lower on Tuesday as the technology sector’s rally ahead of the latest Federal Reserve…
Read More » -
Annovis Bio: Search for efficacy against Alzheimer’s disease (NYSE:ANVS)
D-none Monday, April 29th, Annovis Bio (New York Stock Exchange:ANVS) announced primary results from a phase 2/3 Alzheimer’s disease (AD)…
Read More »
